Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial.

Date publication

janvier 2025

Journal

Annals of the rheumatic diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GOTTENBERG Jacques-Eric

Tous les auteurs :
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, Salliot C, Poiroux L, Nguyen M, Roux CH, Richez C, Saraux A, Vergne-Salle P, Morel J, Flipo RM, Piperno M, Gottenberg JE, Marotte H, Soubrier M, Gossec L, Dieudé P, Lassoued S, Zabraniecki L, Couture G, Boyer JF, Jamard B, Degboe Y, Constantin A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39874233

Résumé

To compare two strategies-a hydrocortisone replacement strategy and a prednisone tapering strategy-for their success in glucocorticoid discontinuation in patients with rheumatoid arthritis (RA) with low disease activity (LDA).

Mots clés

Humans, Arthritis, Rheumatoid, drug therapy, Female, Middle Aged, Male, Double-Blind Method, Prednisone, therapeutic use, Hydrocortisone, administration & dosage, Glucocorticoids, administration & dosage, Aged, Drug Tapering, methods, Treatment Outcome, Antirheumatic Agents, therapeutic use, Severity of Illness Index

Référence

Ann Rheum Dis. 2025 01;84(1):49-59